Micromet

yahoo.com: Zacks Investment Research yahoo.com

Micromet No Longer a Buy (Zacks.com)

yahoo.com     Aug 27, 2008          

Wednesday August 27, 12:13 pm ET By Chris Kallos The recent publication of an article containing positive clinical data from an ongoing phase I trial of Micromet Inc.'s (NasdaqGM: MITI - News) lead candidate, MT103 for...                    

comments

                   
seekingalpha.com: Ohad Hammer seekingalpha.com

Micromet: Another Seal of Approval

seekingalpha.com     Aug 21, 2008   6 related          

Ohad Hammer submits:There is always a debate regarding market efficiency and to what extent stock prices represent the available information about a company. Micromet’s (MITI) surge last week shows that in some cases, the...                    

comments

Micromet: Another Seal of Approval

orglex.com     Aug 21, 2008          

There is always a debate regarding market efficiency and to what extent stock prices represent the available information about a company. Micromet’s (MITI) surge last week shows that in some cases, the market is far from being...                    

comments

                   

Affitech and Omeros Enter Into Antibody Discovery and Development Agreement

redorbit.com     Aug 19, 2008   3 related          

Posted on: Tuesday, 19 August 2008, 03:00 CDT SEATTLE and OSLO, Norway, Aug. 19 /PRNewswire/ -- Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, and Affitech AS, a Norwegian human antibody...                    

comments

                   

SmallCapReview.com: mall Cap Stock Winners - ACFN, XFML, DYAX, MITI

tmcnet.com     Aug 19, 2008          

Acorn Energy (Nasdaq: ACFN) Closed at $4.45, Up $0.16. The increase in second quarter 2008 revenues was attributable to the inclusion in the 2008 period of CoaLogix revenues of $1.3 million and an increase in DSIT revenues of...                    

comments

                   

Accentia pares research costs; Progen resumes enrollment in trial;

drugpolicycentral.com     Aug 18, 2008          

Methadone, a favorite replacement option for heroin in addiction treatment facilities, is also great at relieving pain. Methadone, a favorite replacement option for heroin in addiction treatment facilities, is also great at...                    

comments

                   

OTCPicks.com Stocks to Watch for Monday, August 18th CCMJ, GPIC, MITI, RAMR

emailwire.com     Aug 18, 2008          

Dallas, TX - OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the...                    

comments

                   

Small caps slip as oil recovers (SmallCapInvestor.com)

yahoo.com     Aug 18, 2008          

Monday August 18, 10:14 am ET Small-cap stocks edged lower in relatively calm trading, as a recovery bounce in crude oil on the stock market opening took some of the air out of the morning bullish side of things. News Crude oil...                    

comments

                   
genengnews.com: Genetic Engineering genengnews.com

Micromet test results promising

baltimoresun.com     Aug 15, 2008   21 related          

BETHESDA - Micromet Inc.'s experimental cancer treatment shrank tumors in people with non-Hodgkin's lymphoma in a study that might lead to a new approach in tackling malignant diseases. The medicine, called blinatumomab, caused...                    

comments

                   

Patients ?free from cancer? after immune-boost treatment (en News and International PoliTRICKS:...

puertoblogs.com     Aug 15, 2008   66 related          

Roger Highfield | The Telegraph | August 14, 2008 Cancer patients have been left free of the disease after being treated with a new drug which harnesses the power of their own immune cells. The results have been described as an...                    

comments

1 2 3 4 5 next »